HONG KONGA flurry of Chinese companies including a drug maker and a realestate developer launched Hong Kong initial public offerings seeking to raise as much as roughly US billion and capitalize on recent gains in the citys stock market Luye Pharma Group Ltd partly owned by a group of privateequity firms is seeking to raise up to US million in the biggest of the Hong Kong IPOs launched in recent weeks Hong Kongs benchmark Hang Seng Index is up  since the start of May